Online citations, reference lists, and bibliographies.
← Back to Search

Lipid Mediators, Free Fatty Acids And Psoriasis.

F. Grimminger, P. Mayser
Published 1995 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1159/000249183
Response of psoriatic lesions to multiple applications of leukotriene B4 and 12-HETE.
P. Norris (1987)
10.1111/1523-1747.EP12611380
Enhanced synthesis of cysteinyl leukotrienes in psoriasis.
J. Fauler (1992)
10.1073/PNAS.87.3.909
Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport.
J. Peterson (1990)
10.1111/1523-1747.EP12340250
Lipoxygenation of arachidonic acid by subcellular preparations from murine keratinocytes.
V. Ziboh (1984)
10.1111/1523-1747.EP12531738
Local Effects of Synthetic Leukotrienes (LTC4, LTD4, and LTB4) in Human Skin
N. Soter (1983)
10.3109/09546639109092735
Topical 5-lipoxygenase inhibitors in the treatment of psoriasis
M. Metzman (1991)
10.1111/j.1365-2133.1985.tb15634.x
The role of chemo‐attractant lipoxygenase products in the pathogenesis of psoriasis
R. Camp (1985)
10.1111/j.1365-2133.1991.tb14750.x
The effect of oral indomethacin on psoriasis treated with the Ingram regime
R. Sheehan‐Dare (1991)
Demonstration of leukotriene B4 in the scale extracts of psoriasis and inflammatory pustular dermatoses. Correlation with leukocyte chemotactic activity and C5a anaphylatoxin.
H. Takematsu (1986)
10.1111/1523-1747.EP12873300
Pharmacologic and clinical effects of lonapalene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis.
A. Black (1990)
10.1111/1523-1747.EP12265520
The responses of normal and psoriatic skin to single and multiple topical applications of leukotriene B4.
E. Wong (1985)
10.1111/1523-1747.EP12456188
Anthralin (1,8-dihydroxyanthrone) is a potent inhibitor of leukotriene production and LTB4-omega oxidation by human neutrophils.
J. Schröder (1986)
10.1111/j.1365-2133.1987.tb05910.x
The effects of concomitant administration of oral indomethacin with topical dithranol treatment in psoriasis
L. Shall (1987)
10.1016/0022-202X(89)90182-6
12-Hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) does not stimulate proliferation of human neonatal keratinocytes.
W. Otto (1989)
10.1007/BF00371624
12-Hydroxyeicosatetraenoic acid (12-HETE) is a chemotactic stimulus for epidermal cells
R. Hein (2004)
10.1007/BF00582862
The dermal inflammatory reaction in initial psoriatic lesions
O. Braun-Falco (2004)
10.1016/0090-6980(90)90005-G
Lipid lymphocyte chemoattractants in psoriasis.
K. Bacon (1990)
10.3109/09546639109092732
Effect of fish oil and selective ultraviolet phototherapy on psoriasis vulgaris
S. Cheshmedjieva (1991)
10.1016/0090-1229(91)90029-A
Effect of eicosapentaenoic and docosahexaenoic acid on natural killer cell activity in human peripheral blood lymphocytes.
N. Yamashita (1991)
10.1084/JEM.170.3.847
The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate
J. Schröder (1989)
10.1111/J.1365-2125.1984.TB02499.X
The effect of etretinate on the cyclo-oxygenase and lipoxygenase products of arachidonic acid metabolism in psoriatic skin.
E. Wong (1984)
10.1111/1523-1747.EP12469836
Partial characterization of phospholipase C activity in normal, psoriatic uninvolved, and lesional epidermis.
R. Bartel (1987)
10.1172/JCI114319
A regiospecific monooxygenase with novel stereopreference is the major pathway for arachidonic acid oxygenation in isolated epidermal cells.
M. Holtzman (1989)
Cutaneous responses to lipoxygenase products of arachidonic acid.
Dowd Pm (1985)
10.1111/j.1365-2362.1992.tb01457.x
Defect of epidermal 12(S)‐hydroxyeicosatetraenoic acid receptors in psoriasis
P. Arenberger (1992)
10.1056/NEJM199306243282504
Effect of dietary supplementation with very-long-chain n-3 fatty acids in patients with psoriasis.
E. Søyland (1993)
Human keratinocytes in vitro have receptors for leukotriene B4.
Reusch Mk (1989)
10.1016/0005-2760(86)90284-5
Arachidonic acid metabolism by isolated epidermal basal and differentiated keratinocytes from the hairless mouse.
D. Henke (1986)
10.1073/PNAS.76.2.944
Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties.
P. Needleman (1979)
10.1111/1523-1747.EP12277578
Cytochrome P-450-dependent omega-oxidation of leukotriene B4 in rodent and human epidermis.
H. Mukhtar (1989)
Increased erythrocyte membrane arachidonate and platelet malondialdehyde (MDA) production in psoriasis: normalization after fish-oil.
D. Schena (1989)
10.1111/1523-1747.EP12371740
Interleukin-1 increases 15-hydroxyeicosatetraenoic acid production in human dermal fibroblasts.
N. Godessart (1994)
10.2340/0001555573191193
Modulation of eicosanoid formation by lesional skin of psoriasis: an ex vivo skin model.
K. Fogh (1993)
Platelet-activating factor: a phospholipid autacoid with diverse actions.
M. Venable (1993)
10.1056/NEJM198803033180905
Cardiovascular effects of N-3 fatty acids.
P. C. Weber (1992)
10.1016/0006-291X(83)91572-3
Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid.
D. W. Goldman (1983)
10.1073/PNAS.80.24.7626
Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4.
P. Weller (1983)
10.1001/ARCHDERM.1986.01660230069013
Effects of dietary supplementation of fish oil on neutrophil and epidermal fatty acids. Modulation of clinical course of psoriatic subjects.
V. Ziboh (1986)
10.1111/j.1365-2133.1985.tb15633.x
Pharmacological actions of leukotrienes in the skin
A. Ford-Hutchinson (1985)
Cell damage unmasks 15-lipoxygenase activity in human neutrophils.
J. Mcguire (1985)
10.1056/NEJM198902023200501
The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells.
S. Endres (1989)
10.1111/j.1365-2133.1992.tb08394.x
The immunology of psoriasis
B. Baker (1992)
10.1016/0090-6980(84)90075-3
Biosynthesis and biological activity of leukotriene B5.
T. Terano (1984)
Dietary supplementation with a combination of n-3 and n-6 fatty acids (super gamma-oil marine) improves psoriasis.
K. Kragballe (1989)
10.1177/030006059001800109
Effects of Dietary Supplementation with Polyunsaturated Ethyl Ester Lipids (Angiosan®) in Patients with Psoriasis and Psoriatic Arthritis
A. Lassus (1990)
Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function.
P. G. Swann (1990)
10.1111/J.1365-2125.1986.TB02949.X
Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.
E. Wong (1986)
10.1111/1523-1747.EP12260985
Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin.
J. Grabbe (1984)
10.1111/1523-1747.EP12284061
Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis.
T. Ruzicka (1986)
10.1111/1523-1747.EP12277329
Production of LTB4-like chemotactic arachidonate metabolites from human keratinocytes.
J. Grabbe (1985)
10.1111/1523-1747.EP12523561
In vitro synthesis of 12-hydroxy-eicosatetraenoic acid is increased in uninvolved psoriatic epidermis.
K. Kragballe (1986)
10.1111/1523-1747.EP12470331
Biologic properties of LTB4 and paf-acether in vivo in human skin.
L. Michel (1987)
10.1126/SCIENCE.887938
Glucocorticoid in inflammatory proliferative skin disease reduces arachidonic and hydroxyeicosatetraenoic acids.
S. Hammarstroem (1977)
10.1007/BF00371612
Metabolism of exogenous arachidonic acid by polymorphonuclear leukocytes from psoriatic patients
J. Solà (2004)
10.1111/1523-1747.EP12469865
Leukotriene B4 formation during human neutrophil keratinocyte interactions: evidence for transformation of leukotriene A4 by putative keratinocyte leukotriene A4 hydrolase.
L. Iversen (1993)
10.1159/000210802
Leukotriene B4 receptors on neutrophils in patients with psoriasis and atopic eczema.
F. Meier (1989)
10.1111/1523-1747.EP12462780
Neuropeptides modulate leukotriene B4 mitogenicity toward cultured human keratinocytes.
M. J. Rabier (1993)
Arachidonic acid and leukotrienes in dermatology.
K. Kragballe (1983)
10.1038/254351A0
Inhibitor(s) of prostaglandin synthesis in psoriatic plaque
Neal S. Penneys (1975)
10.1111/1523-1747.EP12276933
Leukotriene B4 and 12-hydroxyeicosatetraenoic acid stimulate epidermal proliferation in vivo in the guinea pig.
C. Chan (1985)
10.1016/0006-291X(86)90891-0
Stereochemical difference between 12-hydroxy-5,8,10,14-eicosatetraenoic acid in platelets and psoriatic lesions.
P. Woollard (1986)
10.1111/j.1365-2133.1991.tb00419.x
Endothelial leucocyte adhesion molecule‐1 (ELAM‐1) expression in cutaneous inflammation
R. Groves (1991)
10.1159/000210754
15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of human neutrophils.
T. Ternowitz (1988)
10.1159/000210962
Clinical and biochemical effects of an oral leukotriene biosynthesis inhibitor (MK886) in psoriasis.
E. D. de Jong (1991)
Abnormal 15-hydroxyeicosatetraenoic acid (15-HETE) formation in psoriatic dermis.
K. Kragballe (1987)
10.1097/00000372-197900130-00002
Evolution, maturation, and regression of lesions of psoriasis: New observations and correlation of clinical and histologic findings
A. Ragaz (1979)
10.1111/j.1365-3083.1990.tb03190.x
Production of 15‐Hydroxyeicosatetraenoic Acid by Purified Human Eosinophils and Neutrophils
E. Morita (1990)
10.1172/JCI110288
Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW F1 mice.
J. Prickett (1981)
A low-fat diet supplemented with dietary fish oil (Max-EPA) results in improvement of psoriasis and in formation of leukotriene B5.
K. Kragballe (1989)
10.1111/j.1476-5381.1983.tb10721.x
Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4
R. Camp (1983)
10.1084/JEM.145.5.1399
Prostaglandin production by rheumatoid synovial cells: stimulation by a factor from human mononuclear Cells
J. Dayer (1977)
10.1038/JID.1989.35
Cutaneous pharmacology: perspectives on the growth of investigation of mediators of inflammation.
R. Camp (1989)
10.1007/BF00412686
Role of Langerhans cells in epidermotropism of T cells
T. Shiohara (2004)
10.1016/0190-9622(90)70103-O
A double-blind vehicle-controlled study of R 68 151 in psoriasis: a topical 5-lipoxygenase inhibitor.
H. Degreef (1990)
10.1016/0090-6980(83)90178-8
The identification of hydroxy fatty acids in psoriatic skin.
R. Camp (1983)
10.1159/000249181
Eicosanoids in psoriasis--15-HETE on the stage.
K. Kragballe (1987)
10.1111/j.1346-8138.1981.tb02551.x
EXACERBATION OF PSORIASIS INDUCED BY INDOMETHACIN
H. Katayama (1981)
10.1016/0002-9343(88)90007-1
Dietary supplementation with omega-3 polyunsaturated fatty acids in patients with stable coronary heart disease. Effects on indices of platelet and neutrophil function and exercise performance.
J. Mehta (1988)
10.1111/1523-1747.EP12455554
In vitro generation of chemotactic leukotrienes from unfractionated murine epidermal cells.
A. Möller (1986)
10.1007/BF00915380
Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid
D. Payan (2004)
10.1056/NEJM198505093121903
Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function
T. Lee (1985)
10.1007/BF00427659
Effect of dithranol treatment on arachidonic acid and its lipoxygenase products in psoriasis
R. Barr (2004)
10.1007/BF00412586
Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) and 5,12-dihydroxyeicosatetraenoic acid (leukotriene B4) in psoriasis and normal human skin
P. Dowd (2004)
10.1001/ARCHDERM.1991.01680050115015
The cytokine network in psoriasis.
B. Nickoloff (1991)
10.1016/0090-6980(85)90186-8
The effects of a diet rich in fish oil on human neutrophils: identification of leukotriene B5 as a metabolite.
S. Prescott (1985)
10.1111/j.1365-2133.1989.tb07765.x
An enzymatic method for distinguishing the stereoisomers of 12‐hydroxyeicosatetraenoic acid in human epidermis and psoriatic scale
E. Opas (1989)
10.1111/j.1365-2133.1985.tb13071.x
(56) Nail dystrophy due to alopecia areata
K. Misch (1985)
10.1111/j.1365-2133.1988.tb01768.x
The pathomechanisms of psoriasis; the skin immune system and cyclosporin
J. Bos (1988)
10.1016/0006-2952(78)90169-7
Prostaglandins and chronic inflammation.
I. Bonta (1978)
10.1111/j.1365-2133.1989.tb01378.x
Double‐blind, placebo‐controlled study to evaluate the efficacy of fish oil and low‐dose UVB in the treatment of psoriasis
A. Gupta (1989)
Besserung klinischer Symptome von Psoriasis durch Fischöl
U. Linker (1991)
10.1007/BF00561448
Synthesis of prostaglandins by psoriatic skin
V. Kassis (2004)
10.1042/CS0740467
Characterization of leukotriene B3: comparison of its biological activities with leukotriene B4 and leukotriene B5 in complement receptor enhancement, lysozyme release and chemotaxis of human neutrophils.
T. Lee (1988)
10.1111/1523-1747.EP12273519
Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin.
V. Ziboh (1984)
10.1016/0005-2760(84)90116-4
Characterization of lipoxygenase metabolites of arachidonic acid in cultured human skin fibroblasts.
B. Mayer (1984)
10.1001/ARCHDERM.1983.01650310010002
Benoxaprofen improves psoriasis. A double-blind study.
K. Kragballe (1983)
10.1111/j.1365-2133.1985.tb15642.x
Inflammatory cell accumulation in response to intracutaneous Paf‐acether: a mediator of acute and persistent inflammation?
C. Archer (1985)
10.1111/j.1365-2133.1987.tb05806.x
Metabolism of [14C]arachidonic acid by polymorphonuclear leukocytes in patients with psoriasis
M. Stüning (1987)
10.7326/0003-4819-106-4-497
Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study.
J. Kremer (1987)
10.1111/1523-1747.EP12480558
Metabolism of arachidonic acid by human epidermal cells depends upon maturational stage.
H. Henneicke-von Zepelin (1991)
Stereospecificity of the products of the fatty acid oxygenases derived from psoriatic scales.
A. Baer (1991)
Metabolism of leukotriene B4 by cultured human keratinocytes. Formation of glutathione conjugates and dihydro metabolites.
P. Wheelan (1993)
10.3109/09546639309088234
The effect of combined fish oil and evening primrose oil (Efamol Marine) on the remission phase of psoriasis: A 7-month double-blind randomized placebo-controlled trial
A. Strong (1993)
10.1002/ARDP.19943270103
5‐Lipoxygenase and 12‐Lipoxygenase: Attractive Targets for the Development of Novel Antipsoriatic Drugs. 5‐Lipoxygenase und 12‐Lipoxygenase: Attraktive Target‐Enzyme für die Entwicklung neuer Antipsoriatika
K. Müller (1994)
10.1016/S0190-9622(89)80363-9
Effect of highly purified eicosapentaenoic acid on psoriasis.
T. Kojima (1989)
A fish oil diet rich in eicosapentaenoic acid reduces cyclooxygenase metabolites, and suppresses lupus in MRL-lpr mice.
V. Kelley (1985)
10.1073/PNAS.84.22.8125
12(R)-hydroxyicosatetraenoic acid: a cytochrome-P450-dependent arachidonate metabolite that inhibits Na+,K+-ATPase in the cornea.
M. Schwartzman (1987)
10.1111/1523-1747.EP12260955
Mast cell degranulation in the evolution of acute eruptive guttate psoriasis vulgaris.
I. Brody (1984)
10.1007/BF00511071
Release of lipoxygenase products of arachidonic acid from freshly isolated human keratinocytes
J. Grabbe (2004)
10.1016/0163-7827(86)90056-1
The conversion of dietary eicosapentaenoic acid to prostanoids and leukotrienes in man.
P. C. Weber (1986)
Biosynthèse des prostaglandines dans l'épiderme psoriasique.
B. Michel (1980)
The physiology and pathophysiology of eicosanoids in the skin.
T. Ruzicka (1988)
Leukotrienes augment interleukin 1 production by human monocytes.
M. Rola-Pleszczynski (1985)
10.1111/j.1365-2133.1985.tb02043.x
Leukotrienes B4, C4 and D4 stimulate DNA synthesis in cultured human epidermal keratinocytes
K. Kragballe (1985)
10.1111/j.1365-2133.1989.tb01335.x
Topical eicosapentaenoic acid (EPA) in the treatment of psoriasis
Catherine E.Dewsbury (1989)
10.1007/BF00638234
Leukotriene B4 and platelet-activating factor in human skin
L. Michel (2004)
10.1007/BF00372055
The effect of topical retinoids on the leukotriene-B4-induced migration of polymorphonuclear leukocytes into human skin
G. Wozel (2004)
10.1007/BF00376623
Dithranol-induced down-regulation of 12(S)-hydroxyeicosatetraenoic acid [12(S)-HETE] receptors in a human epidermal cell line
L. Kemény (2004)
10.1177/096032718700600308
Effect of Dietary Fish Oil on Hyperlipidaemia due to Isotretinoin and Etretinate
J. Marsden (1987)
10.1111/1523-1747.EP12475450
Enzymatic properties of the 15-lipoxygenase of human cultured keratinocytes.
B. Burrall (1988)
10.1111/J.1365-2125.1987.TB03184.X
Lack of effect of topical indomethacin on psoriasis.
C. Green (1987)
10.1111/1523-1747.EP12525265
Effects of chronic intracutaneous administration of arachidonic acid and its metabolites. Induction of leukocytoclastic vasculitis by leukotriene B4 and 12-hydroxyeicosatetraenoic acid and its prevention by prostaglandin E2.
T. Ruzicka (1987)
10.1001/ARCHDERM.1982.01650210032013
Stripping of the stratum corneum in patients with psoriasis: production of prepinpoint papules and psoriatic lesions.
S. Jabłońska (1982)
Biosynthesis of paf-acether factor-acether by human skin fibroblasts in vitro.
L. Michel (1988)
10.1111/j.1365-4362.1986.tb02240.x
Prostaglandin E2 Gel Improvement of Psoriatic Lesions
W. Remy (1986)
10.1111/j.1365-2133.1993.tb03338.x
Highly purified omega‐3‐polyunsaturated fatty acids for topical treatment of psoriasis. Results of a double‐blind, placebo‐controlled multicentre study
H.‐H. HENNEICKE‐VON ZEPELIN (1993)
Differential effects of leukotriene B4 on T4+ and T8+ lymphocyte phenotype and immunoregulatory functions.
M. Rola-Pleszczynski (1985)
10.1111/1523-1747.EP12505563
Production of paf-acether by human epidermal cells.
L. Michel (1990)
10.1016/0006-291X(81)91266-3
Selective feed-back inhibition of the 5-lipoxygenation of arachidonic acid in human T-lymphocytes.
E. Goetzl (1981)
10.1001/ARCHDERM.1983.01650310003001
Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses.
J. Voorhees (1983)
Membrane-bound phospholipase C activity in normal and psoriatic epidermis.
M. Bergers (1990)
10.1093/AJCN/53.3.620
Changes in fatty acid composition in rat blood and organs after infusion of docosahexaenoic acid ethyl ester.
K. Yamazaki (1991)
10.1111/j.1365-2133.1987.tb05900.x
Reduction of leukotriene B4‐induced intraepidermal accumulation of polymorphonuclear leukocytes by methotrexate in psoriasis
A. Lammers (1987)
10.1016/0262-1746(86)90187-3
Stimulation of interleukin 2 and interferon gamma production by leukotriene B4 in human lymphocyte cultures.
M. Rola-Pleszczynski (1986)
10.1016/S0190-9622(88)70133-4
The effect of dietary fish oil supplementation on psoriasis. Improvement in a patient with pustular psoriasis.
A. Kettler (1988)
10.1016/0262-1746(85)90064-2
Polymorphonuclear leukocyte 5-lipoxygenase activity in psoriasis.
T. Ruzicka (1985)
10.1111/1523-1747.EP12874064
Comparison of eicosanoid generation by highly purified human Langerhans cells and keratinocytes.
T. Rosenbach (1990)
10.1016/S0140-6736(88)91181-6
A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED TRIAL OF FISH OIL IN PSORIASIS
S. B. Bittiner (1988)
10.1016/0006-291X(85)90590-X
Structural identification of platelet activating factor in psoriatic scale.
A. Mallet (1985)
10.1111/j.1365-2133.1987.tb07492.x
The effects of dietary supplementation with fish oil in patients with psoriasis
Philippe Maurice (1987)
10.1111/j.1476-5381.1985.tb11082.x
Inhibition of ionophore‐stimulated leukotriene B4 production in human leucocytes by monohydroxy fatty acids
R. Camp (1985)
10.1111/j.1365-2362.1993.tb00750.x
Very long chain n‐3 and n‐6 polyunsaturated fatty acids inhibit proliferation of human T‐lymphocytes in vitro
E. Søyland (1993)
10.1111/1523-1747.EP12261712
The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis.
S. Brain (1984)
Eicosanoids and the Skin
T. Ruzicka (1990)
10.1016/S0190-9622(88)70154-1
Fish oil supplementation results in decreased hypertriglyceridemia in patients with psoriasis undergoing etretinate or acitretin therapy.
J. M. Ashley (1988)
10.1016/0090-6980(84)90113-8
The analysis of arachidonic acid metabolites in normal, uninvolved and lesional psoriatic skin.
R. Barr (1984)
10.1016/S0190-9622(88)70040-7
Improvement of psoriasis vulgaris after intralesional injections of 15-hydroxyeicosatetraenoic acid (15-HETE).
K. Fogh (1988)
10.1016/0090-6980(87)90264-4
12(R)-hydroxy-5,8,10,14-eicosatetraenoic acid is a chemoattractant for human polymorphonuclear leucocytes in vitro.
F. Cunningham (1987)
10.1016/0005-2760(87)90179-2
Conversion of linoleic acid and arachidonic acid by skin epidermal lipoxygenases.
D. Nugteren (1987)
10.1111/1523-1747.EP12874543
High-affinity binding and lack of growth-promoting activity of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) in a human epidermal cell line.
Erhard Gross (1990)
10.1016/0090-6980(85)90093-0
Effects of 9-deoxo-16,16-dimethyl-9-methylene PGE2 on muscle contractile activity and collagen synthesis in the human cervix.
A. Norström (1985)
10.1111/j.1365-2133.1984.tb04712.x
Confirmation of raised phospholipase A2 activity in the uninvolved skin of psoriasis
A. Verhagen (1984)
10.1111/j.1365-2133.1984.tb07310.x
Inflammatory characteristics of platelet activating factor (PAF‐acether) in human skin
C. Archer (1984)
Arachidonic acid metabolism among human mononuclear leukocytes. Lipoxygenase-related pathways.
M. Goldyne (1984)
10.1016/0005-2760(83)90295-3
Epidermal arachidonate lipoxygenase.
T. Ruzicka (1983)
10.1016/S0140-6736(82)90939-4
PSORIASIS AND LEUKOTRIENE B4
S. Brain (1982)
10.1007/BF00413280
Heterogeneous distribution of lipoxygenase products in psoriatic skin lesions
K. Fogh (2004)
10.1016/0006-2952(84)90220-X
Benoxaprofen does not inhibit formation of leukotriene B4 in a model of acute inflammation.
J. A. Salmon (1984)
10.1016/S0140-6736(77)90264-1
DOPAMINE-INDUCED ISCHEMIA
T. Ebels (1977)
10.1111/1523-1747.EP12476562
Determination of 5,12, and 15-lipoxygenase products in keratomed biopsies of normal and psoriatic skin.
E. Duell (1988)
10.1111/j.1365-2133.1985.tb15647.x
Generation of leukotrienes from normal epidermis and their demonstration in cutaneous disease
T. Rosenbach (1985)
10.1111/j.1365-2133.1987.tb04112.x
Polymorphonuclear leukocyte function in psoriasis vulgaris
C. Pease (1987)
10.1111/j.1365-4362.1990.tb03477.x
The Role of Fish Oil in Psoriasis
A. Gupta (1990)
10.1111/j.1365-2133.1986.tb02843.x
Epidermal hyperproliferation following the induction of microabscesses by leukotriene B4
F. Bauer (1986)
10.1016/0090-6980(85)90097-8
Evaluation of inhibitors of eicosanoid synthesis in leukocytes: possible pitfall of using the calcium ionophore A23187 to stimulate 5' lipoxygenase.
J. A. Salmon (1985)
10.1038/JID.1989.15
Lymphocyte recognition of psoriatic endothelium: evidence for a tissue-specific receptor/ligand interaction.
Y. H. Chin (1989)
10.1111/1523-1747.EP12696858
Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions.
K. Fogh (1989)
10.1111/1523-1747.EP12555582
Increased phospholipase C-catalyzed hydrolysis of phosphatidylinositol-4,5-bisphosphate and 1,2-sn-diacylglycerol content in psoriatic involved compared to uninvolved and normal epidermis.
G. Fisher (1990)
10.1038/287147A0
Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids
G. J. Blackwell (1980)
10.1001/ARCHDERM.1976.01630310017003
Pathogenesis of Woronoff ring in psoriasis.
N. Penneys (1976)
10.1111/1523-1747.EP12470151
Inhibition by leukotriene B5 of leukotriene B4-induced activation of human keratinocytes and neutrophils.
K. Kragballe (1987)
10.1016/0090-6980(87)90109-2
The metabolism of leukotriene B4 by peripheral blood polymorphonuclear leukocytes in psoriasis.
Philippe Maurice (1987)
Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenase product.
T. H. Lee (1984)
10.1111/j.1365-2133.1988.tb03218.x
Characterization of specific leukotriene C4 binding sites on cultured human keratinocytes
A. Muller (1988)
10.1152/AJPCELL.1994.266.1.C243
Epidermis contains platelet-type 12-lipoxygenase that is overexpressed in germinal layer keratinocytes in psoriasis.
H. Hussain (1994)
10.1111/1523-1747.EP12499800
Epidermal cell-polymorphonuclear leukocyte cooperation in the formation of leukotriene B4 by transcellular biosynthesis.
J. Solà (1992)
Fatty acid intake and Kupffer cell function: fish oil alters eicosanoid and monokine production to endotoxin stimulation.
T. Billiar (1988)
10.1016/0090-6980(85)90084-X
Leukotrienes C4 and D4 in psoriatic skin lesions.
S. Brain (1985)
10.1111/1523-1747.EP12273537
Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE).
P. Dowd (1985)
10.1001/ARCHDERM.1986.01660200049012
Selective decrease of 15-hydroxyeicosatetraenoic acid (15-HETE) formation in uninvolved psoriatic dermis.
K. Kragballe (1986)
10.1007/BF00455325
15-Hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits the LTB4-induced skin response
T. Ternowitz (2004)
10.1111/j.1365-2133.1983.tb04585.x
The level of phospholipase A2 activity is raised in the uninvolved epidermis of psoriasis
S. Forster (1983)
In vivo chemotaxis of bovine neutrophils induced by 5-lipoxygenase metabolites of arachidonic and eicosapentaenoic acid.
J. Heidel (1989)
10.1016/0140-6736(91)90357-U
The pathophysiology of psoriasis
J. Barker (1991)
10.1016/0024-3205(86)90143-8
Dietary fish oils reduce plasma levels of platelet activating factor precursor (lyso-PAF) in rats.
K. Croft (1986)
10.1073/PNAS.80.14.4349
Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils.
E. Ham (1983)
10.1111/1523-1747.EP12581645
Arachidonic acid transformations in normal and psoriatic skin.
S. Hammarstroem (1979)
10.1111/j.1365-2133.1987.tb07484.x
Leukotriene B4 fails to induce penetration of lymorphonuclear leukocytes into psoriatic lesions
A. Lammers (1987)
10.1016/0952-3278(88)90024-5
Comparative effect of leukotriene B4 and leukotriene B5 on calcium mobilization in human neutrophils.
A. Seya (1988)
10.1111/j.1365-2133.1987.tb07364.x
Exacerbation of psoriasis by indomethacin
A. Powles (1987)
10.1111/j.1476-5381.1984.tb10148.x
Leukotriene B4‐like material in scale of psoriatic skin lesions
S. Brain (1984)
Inhibition of leukotriene biosynthesis by the leukocyte product 15-hydroxy-5,8,11,13-eicosatetraenoic acid.
J. Y. Vanderhoek (1980)
10.1111/j.1365-2133.1988.tb01753.x
Effect of dietary supplementation with n‐3 fatty acids on clinical manifestations of psoriasis
A. Bjørneboe (1988)
10.1111/j.1365-2133.1983.tb04000.x
Generalized pustular psoriasis precipitated by phenylbutazone and oxyphenbutazone
H. Reshad (1983)
10.1111/j.1365-2133.1985.tb02049.x
A dimethoxynaphthalene derivative (RS‐43179 gel) compared with 0.025% fluocinolone acetonide gel in the treatment of psoriasis
A. Lassus (1985)
10.1111/j.1365-2230.1992.tb00194.x
Topical fish oil in psoriasis—a controlled and blind study
S. Escobar (1992)
10.1111/1523-1747.EP12874434
Arachidonic acid metabolism varies with the state of differentiation in density gradient-separated mouse epidermal cells.
G. Cameron (1990)
Effect of lipoxygenase metabolites of arachidonic acid on proliferation of human T cells and T cell subsets.
N. Gualde (1985)
10.1111/1523-1747.EP12259945
Production of intraepidermal microabscesses by topical application of leukotriene B4.
R. Camp (1984)
10.1016/0014-4827(90)90006-V
Regulation of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) binding sites on human epidermal cells by interferon-gamma.
R. Suess (1990)
10.1111/1523-1747.EP12371772
Leukotriene A4 hydrolase in human skin.
K. Ikai (1994)
Original ArticleAnthralin (1,8-Dihydroxyanthrone) Is a Potent Inhibitor of Leukotriene Production and LTB4-ω Oxidation by Human Neutrophils
Jens-M. Schröder (1986)
The biosynthesis of prostaglandins in psoriatic skin.
E. Panconesi (1979)
10.7326/0003-4819-75-4-659_3
Dermatology in general medicine
T. Fitzpatrick (1971)
10.1159/000210811
Migration of polymorphonuclear leukocytes in psoriasis.
P. V. D. van de Kerkhof (1989)
[Prostaglandin biosynthesis in psoriatic epidermis (author's transl)].
B. Michel (1980)
10.1111/j.1365-2796.1989.tb01421.x
Does fish oil protect renal function in cyclosporin‐treated psoriasis patients?
T. Stoof (1989)
10.1111/j.1365-2133.1976.tb15529.x
Leukotactic properties of soluble substances inpsoriasis scale
H. Tagami (1976)
10.1111/j.1365-2133.1986.tb02779.x
Arachidonic acid metabolism by polymorphonuclear leukocytes in psoriasis
Philippe Maurice (1986)
On the origin of 12-hydroxyeicosatetraenoic acid in psoriatic scale.
Humes Jl (1989)
10.1111/1523-1747.EP12876260
Metabolism of exogenous leukotrienes by cultured human keratinocytes.
J. Morelli (1990)
10.1111/1523-1747.EP12455564
Dermis-derived 15-hydroxy-eicosatetraenoic acid inhibits epidermal 12-lipoxygenase activity.
K. Kragballe (1986)



This paper is referenced by
10.3109/09546639609089550
Reproducible effects of intravenously administered fish oil in acute relapsing psoriasis
P. Mayser (1996)
10.1016/S0190-9622(98)70114-8
ω-3 Fatty acid–based lipid infusion in patients with chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, multicenter trial
P. Mayser (1998)
10.1007/978-1-62703-095-3_16
Transient Receptor Potential Channels and Pruritus
H. Benecke (2012)
10.1007/s00134-003-1900-2
ω-3 vs. ω-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation
K. Mayer (2003)
Dietary Fish Oil Suppresses Experimental Immunoglobulin A Nephropathy in Mice 1
J. Pestka (2002)
10.1533/9780857093059.60
DIETARY n-3 POLYUNSATURATED FATTY ACIDS SUPPRESS REPARATIVE REGENERATION OF THE RAT LIVER CONNECTIVE TISSUE
A. Arend (1996)
10.1079/PNS19960069
Immunomodulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids
P. C. Calder (1996)
Peptides as inhibitors of lipoxygenase and tyrosinase
M. Minderhout-Schurink (2007)
10.1001/ARCHDERM.136.5.609
Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation.
C. Ellis (2000)
10.1007/s00011-009-0065-z
Enhanced topical delivery and ex vivo anti-inflammatory activity from a betamethasone dipropionate formulation containing fish oil
M. H. Zulfakar (2009)
10.1097/00075197-199803000-00006
Clinical use of lipids to control inflammatory disease.
K. Mayer (1998)
10.1007/978-1-62703-095-3
TRP Channels in Drug Discovery
A. Szallasi (2012)
10.1111/J.1540-9740.2004.02992.X
The role of fish oils in psoriasis.
J. Rackal (2004)
10.2147/PTT.S24755
The management of psoriasis through diet
G. Duarte (2012)
10.1046/J.1468-3083.2003.00715.X
Erythema annulare centrifugum‐type psoriasis: a particular variant of acute‐eruptive psoriasis
E. Vocks (2003)
10.1016/j.jasms.2008.01.007
Structural characterization of monohydroxyeicosatetraenoic acids and dihydroxy- and trihydroxyeicosatrienoic acids by ESI-FTICR
L. Cui (2008)
Coriodermina Jalea: fortaleza, concentración o dosis por unidad posológica
Gabriel Coto Valdés (2012)
Maisto įtaka žvynelinės kontrolei ir gydymui, remiantis klinikinių tyrimų duomenimis
Indrė Domarkaitė-Jakovlevė (2012)
10.1079/BJN2001459
n-3 fatty acids in psoriasis.
P. Mayser (2002)
Systemic vitamin D and fish oil in the management of psoriasis
Allison R Larson (2016)
10.1111/j.1440-1797.2004.00320.x
Managing Henoch–Schonlein purpura in children with fish oil and ACE inhibitor therapy
M. Dixit (2004)
10.1111/j.1365-2133.2005.06781.x
Diet and psoriasis: experimental data and clinical evidence
M. Wolters (2005)
10.1111/J.1753-4887.1998.TB01648.X
Dietary fatty acids and the immune system.
P. Calder (1998)
10.18632/oncotarget.21562
Untargeted serum metabonomics study of psoriasis vulgaris based on ultra-performance liquid chromatography coupled to mass spectrometry
L. Li (2017)
10.1590/S0100-879X1998000400002
Immunoregulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids.
P. C. Calder (1998)
10.1093/JN/132.2.261
Dietary fish oil suppresses experimental immunoglobulin a nephropathy in mice.
J. Pestka (2002)
Immunomodulatory and anti-inflammatory effects of 12-3 polyunsaturated fatty acids
D. Cuthbertson (2005)
Emerging concepts in diet and psoriasis : importance of functional foods
Gleison Duarte (2012)
10.1164/RCCM.200207-674OC
Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis.
K. Mayer (2003)
10.1093/CARCIN/20.2.249
Fish oil constituent docosahexa-enoic acid selectively inhibits growth of human papillomavirus immortalized keratinocytes.
D. Chen (1999)
10.3390/genes11101155
Transcriptome Profiling Analyses in Psoriasis: A Dynamic Contribution of Keratinocytes to the Pathogenesis
Geneviève Rioux (2020)
10.1054/CLNU.1999.0072
Fish oil emulsions: what benefits can they bring?
P. Fürst (2000)
See more
Semantic Scholar Logo Some data provided by SemanticScholar